Page last updated: 2024-08-23

etoposide and streptonigrin

etoposide has been researched along with streptonigrin in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's5 (45.45)18.2507
2000's3 (27.27)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furbacher, TR; Gunatilaka, AA1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Carter, SK; Muggia, FM; Rozencweig, M; Slavik, M1
Fujii, N; Kawada, S; Nakano, H; Yamashita, Y1
Jaspers, NG; Jongmans, W; Lohman, PH; Morolli, B; van der Schans, GP; Verhaegh, GW; Zdzienicka, MZ1
Jongmans, W; Lohman, PH; Sankaranarayanan, K; Verhaegh, GW; Zdzienicka, MZ1
Bay, JO; Bignon, YJ; Pernin, D; Uhrhammer, N1
Johnson, MA; Jones, NJ1
Bryant, PE; Johnson, MA; Jones, NJ1
Furuse, H; Ishii, Y; Kai, F; Nagata, M; Otsuka, A; Ozono, S; Sugiyama, T; Suzuki, T; Takayama, T; Yajima, T1

Other Studies

11 other study(ies) available for etoposide and streptonigrin

ArticleYear
Catalytic inhibition of topoisomerase IIalpha by demethylzeylasterone, a 6-oxophenolic triterpenoid from Kokoona zeylanica.
    Journal of natural products, 2001, Volume: 64, Issue:10

    Topics: Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Catalysis; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; Electrophoresis, Agar Gel; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Female; Glioma; Humans; Inhibitory Concentration 50; Lung Neoplasms; Methyl Green; Molecular Structure; Plants, Medicinal; Saccharomyces cerevisiae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Triterpenes; Tumor Cells, Cultured

2001
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Overview of early and investigational chemotherapeutic agents in solid tumors.
    Medical and pediatric oncology, 1976, Volume: 2, Issue:4

    Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Aziridines; Azo Compounds; Camptothecin; Cycloleucine; Etoposide; Floxuridine; Humans; Neoplasms; Nitrogen Mustard Compounds; Picolinic Acids; Platinum; Porfiromycin; Streptonigrin; Teniposide; Thiotepa; Tubercidin

1976
Induction of mammalian DNA topoisomerase II dependent DNA cleavage by antitumor antibiotic streptonigrin.
    Cancer research, 1990, Sep-15, Volume: 50, Issue:18

    Topics: DNA; DNA Damage; DNA Topoisomerases, Type II; Etoposide; Streptonigrin

1990
A novel type of X-ray-sensitive Chinese hamster cell mutant with radioresistant DNA synthesis and hampered DNA double-strand break repair.
    Mutation research, 1995, Volume: 337, Issue:2

    Topics: Animals; Bleomycin; Cell Survival; CHO Cells; Cricetinae; DNA; DNA Damage; DNA Repair; DNA Replication; Enzyme Inhibitors; Etoposide; Free Radicals; Gamma Rays; Genetic Complementation Test; Mitomycin; Mutagens; Radiation, Ionizing; Streptonigrin; Topoisomerase I Inhibitors; X-Rays

1995
Cellular characteristics of Chinese hamster cell mutants resembling ataxia telangiectasia cells.
    Mutation research, 1993, Volume: 294, Issue:3

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Ataxia Telangiectasia; Cell Line; Cell Survival; Cricetinae; Doxorubicin; Enediynes; Etoposide; Humans; Hypoxanthine Phosphoribosyltransferase; Mutagens; Mutation; Streptonigrin

1993
ATM heterozygote cells exhibit intermediate levels of apoptosis in response to streptonigrin and etoposide.
    European journal of cancer (Oxford, England : 1990), 1999, Volume: 35, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ataxia Telangiectasia; Cell Line; Etoposide; Genetic Carrier Screening; Heterozygote; Humans; Streptonigrin

1999
The isolation and genetic analysis of V79-derived etoposide sensitive Chinese hamster cell mutants: two new complementation groups of etoposide sensitive mutants.
    Mutation research, 1999, Dec-07, Volume: 435, Issue:3

    Topics: Animals; Camptothecin; Cell Separation; CHO Cells; Cricetinae; Doxorubicin; Etoposide; Genetic Complementation Test; Mitomycin; Mutation; Nucleic Acid Hybridization; Streptonigrin; Topoisomerase II Inhibitors

1999
Isolation of camptothecin-sensitive chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group.
    Mutagenesis, 2000, Volume: 15, Issue:4

    Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Bleomycin; Camptothecin; Cell Cycle; Cell Cycle Proteins; Cell Line; Cricetinae; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Enzyme Inhibitors; Etoposide; Gamma Rays; Genes, Dominant; Genetic Complementation Test; Mitomycin; Mutation; Nucleic Acid Synthesis Inhibitors; Phenotype; Protein Serine-Threonine Kinases; Streptonigrin; Tumor Suppressor Proteins

2000
[Salvage therapy for castration-refractory prostate cancer resistant to docetaxel].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2013, Volume: 104, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Docetaxel; Drug Combinations; Drug Resistance, Neoplasm; Etoposide; Humans; Male; Middle Aged; Oxonic Acid; Paclitaxel; Prostatic Neoplasms, Castration-Resistant; Salvage Therapy; Streptonigrin; Taxoids; Tegafur; Uracil

2013